z-logo
open-access-imgOpen Access
Secondary Central Nervous System Lymphoma as a Complication from a Systemic Non-Hodgkin Lymphoma
Author(s) -
Rodríguez-Leyva Ildefons,
Rodríguez-Rivas Ricardo
Publication year - 2021
Publication title -
journal of infectious diseases and case reports
Language(s) - English
Resource type - Journals
ISSN - 2634-8861
DOI - 10.47363/jidscr/2021(2)139
Subject(s) - medicine , prednisone , lymphoma , vincristine , hyperreflexia , weakness , pathology , cyclophosphamide , surgery , chemotherapy
Secondary central nervous system lymphoma is a complication from non-Hodgkin lymphoma not very well known. NHL can present in a variety of neurological clinical presentations varying from primary central nervous system lymphoma to complications from a systemic disease like metastasis or peripheral nerve involvement. We present a case of a 78-year-old male with Diffuse large B-cell lymphoma, treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. Six months later of the diagnosis, the patient presented to the emergency department, complaining of five days with progressive weakness in the left upper limb, and two days before the weakness developed in the left lower limb. On the neurologic examination with inattention, dysarthria, left central facial nerve palsy, severe weakness on the left hemibody with hyperreflexia, and left extensor plantar response. Brain Magnetic resonance imaging reported three metastatic lesions, with a final diagnosis of secondary central nervous system lymphoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here